Detailed Mechanism Funding and Narrative

Years of mechanism: 2011 2012 2013 2014 2015 2016

Details for Mechanism ID: 13104
Country/Region: Uganda
Year: 2016
Main Partner: Baylor College of Medicine
Main Partner Program: Children's Foundation
Organizational Type: University
Funding Agency: HHS/CDC
Total Funding: $0 Additional Pipeline Funding: N/A

NOTE: PEPFAR no longer creates activity narratives for each mechanism. In their place, PEPFAR has begun releasing mechanism specific targets that reveal the achievements and programs that are expected of the funding. If available for this mechanism, these targets are presented below.

Mechanism Allocation by Budget Code for Selected Year
Care: Adult Care and Support (HBHC) $0
Care: Orphans and Vulnerable Children (HKID) $0
Care: TB/HIV (HVTB) $0
Care: Pediatric Care and Support (PDCS) $0
Laboratory Infrastructure (HLAB) $0
Health Systems Strengthening (OHSS) $0
Biomedical Prevention: Voluntary Medical Male Circumcision (CIRC) $0
Testing: HIV Testing and Counseling (HVCT) $0
Sexual Prevention: Other Sexual Prevention (HVOP) $0
Biomedical Prevention: Prevention of Mother to Child Transmission (MTCT) $0
Treatment: Adult Treatment (HTXS) $0
Treatment: Pediatric Treatment (PDTX) $0
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

MER Indicator MER description Target Fiscal Year Target
GEND_GBV Age/Sex: <10 Female 2017 38
GEND_GBV Age/Sex: <10 Female 2017 98
GEND_GBV Age/Sex: <10 Male 2017 23
GEND_GBV Age/Sex: <10 Male 2017 59
GEND_GBV Age/Sex: 10-14 Female 2017 96
GEND_GBV Age/Sex: 10-14 Female 2017 276
GEND_GBV Age/Sex: 10-14 Male 2017 23
GEND_GBV Age/Sex: 10-14 Male 2017 59
GEND_GBV Age/Sex: 15-19 Female 2017 174
GEND_GBV Age/Sex: 15-19 Female 2017 494
GEND_GBV Age/Sex: 15-19 Male 2017 32
GEND_GBV Age/Sex: 15-19 male 2017 96
GEND_GBV Age/Sex: 20-24 Female 2017 157
GEND_GBV Age/Sex: 20-24 Female 2017 475
GEND_GBV Age/Sex: 20-24 Male 2017 38
GEND_GBV Age/Sex: 20-24 Male 2017 98
GEND_GBV Age/Sex: 25-49 Female 2017 65
GEND_GBV Age/Sex: 25-49 Female 2017 199
GEND_GBV Age/Sex: 25-49 Male 2017 38
GEND_GBV Age/Sex: 25-49 Male 2017 98
GEND_GBV By PEP service provision (related to sexual violence services provided) 2017 63
GEND_GBV By PEP service provision (related to sexual violence services provided) 2017 176
GEND_GBV By type of service: Physical and/or Emotional Violence (Other Post-GBV Care) 2017 151
GEND_GBV By type of service: Physical and/or Emotional Violence (Other Post-GBV Care) 2017 428
GEND_GBV By type of service: Sexual Violence (Post-Rape Care) 2017 533
GEND_GBV By type of service: Sexual Violence (Post-Rape Care) 2017 1,524
GEND_GBV Number of people receiving post-GBV care 2017 684
GEND_GBV Number of people receiving post-GBV care 2017 1,952
GEND_GBV Sum of Age/Sex Disaggregates 2017 180
GEND_GBV Sum of Age/Sex Disaggregates 2017 492
HTS_TST Age/sex: <1 2017 295
HTS_TST Age/sex: <1 2017 1,534
HTS_TST Age/sex: 1-9 2017 958
HTS_TST Age/sex: 1-9 2017 5,038
HTS_TST Age/sex: 10-14 Female 2017 827
HTS_TST Age/sex: 10-14 Female 2017 4,343
HTS_TST Age/sex: 10-14 Male 2017 829
HTS_TST Age/sex: 10-14 Male 2017 4,347
HTS_TST Age/sex: 15-19 Female 2017 4,728
HTS_TST Age/sex: 15-19 Female 2017 15,337
HTS_TST Age/sex: 15-19 Male 2017 2,912
HTS_TST Age/sex: 15-19 Male 2017 12,946
HTS_TST Age/sex: 20-24 Female 2017 7,090
HTS_TST Age/sex: 20-24 Female 2017 23,002
HTS_TST Age/sex: 20-24 Male 2017 4,367
HTS_TST Age/sex: 20-24 Male 2017 19,417
HTS_TST Age/sex: 25-49 Female 2017 10,865
HTS_TST Age/sex: 25-49 Female 2017 35,263
HTS_TST Age/sex: 25-49 Male 2017 6,696
HTS_TST Age/sex: 25-49 Male 2017 29,773
HTS_TST Age/sex: 50+ Female 2017 939
HTS_TST Age/sex: 50+ Female 2017 3,061
HTS_TST Age/sex: 50+ Male 2017 580
HTS_TST Age/sex: 50+ Male 2017 2,582
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Female 2017 1,454
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Female 2017 7,630
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Male 2017 1,455
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Male 2017 7,632
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Female 2017 23,622
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Female 2017 76,663
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Male 2017 14,555
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Male 2017 64,718
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2017 41,086
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2017 156,643
HTS_TST Service Delivery Point (Facility): Index testing 2017 1,097
HTS_TST Service Delivery Point (Facility): Index testing 2017 1,942
HTS_TST Service Delivery Point (Facility): Inpatient 2017 7,960
HTS_TST Service Delivery Point (Facility): Inpatient 2017 25,864
HTS_TST Service Delivery Point (Facility): Other PITC 2017 1,975
HTS_TST Service Delivery Point (Facility): Other PITC 2017 7,059
HTS_TST Service Delivery Point (Facility): Outpatient 2017 15,323
HTS_TST Service Delivery Point (Facility): Outpatient 2017 60,483
HTS_TST Service Delivery Point (Facility): Pediatric 2017 2,611
HTS_TST Service Delivery Point (Facility): Pediatric 2017 14,446
HTS_TST Service Delivery Point (Facility): PMTCT 2017 11,901
HTS_TST Service Delivery Point (Facility): PMTCT 2017 34,007
HTS_TST Service Delivery Point (Facility): TB Clinics 2017 219
HTS_TST Service Delivery Point (Facility): TB Clinics 2017 767
HTS_TST Service Delivery Point (Facility): VMMC 2017 12,075
HTS_TST Sum of Age/Sex disaggregates 2017 39,833
HTS_TST Sum of Age/Sex disaggregates 2017 150,071
HTS_TST Sum of Aggregated Age/Sex <15 2017 2,909
HTS_TST Sum of Aggregated Age/Sex <15 2017 15,262
HTS_TST Sum of Aggregated Age/Sex 15+ 2017 38,177
HTS_TST Sum of Aggregated Age/Sex 15+ 2017 141,381
HTS_TST Sum of Aggregated Age/Sex disaggregates 2017 41,086
HTS_TST Sum of Aggregated Age/Sex disaggregates 2017 156,643
HTS_TST_POS Test Result by Age and Sex: Positive: 10-14 Female 2017 26
HTS_TST_POS Test Result by Age and Sex: Positive: 10-14 Female 2017 102
HTS_TST_POS Test Result by Age and Sex: Positive: 10-14 Male 2017 19
HTS_TST_POS Test Result by Age and Sex: Positive: 10-14 Male 2017 96
HTS_TST_POS Test Result by Age and Sex: Positive: 15-19 Female 2017 88
HTS_TST_POS Test Result by Age and Sex: Positive: 15-19 Female 2017 296
HTS_TST_POS Test Result by Age and Sex: Positive: 15-19 Male 2017 54
HTS_TST_POS Test Result by Age and Sex: Positive: 15-19 Male 2017 205
HTS_TST_POS Test Result by Age and Sex: Positive: 20-24 Female 2017 131
HTS_TST_POS Test Result by Age and Sex: Positive: 20-24 Female 2017 444
HTS_TST_POS Test Result by Age and Sex: Positive: 20-24 Male 2017 82
HTS_TST_POS Test Result by Age and Sex: Positive: 20-24 Male 2017 306
HTS_TST_POS Test Result by Age and Sex: Positive: 25-49 Female 2017 201
HTS_TST_POS Test Result by Age and Sex: Positive: 25-49 Female 2017 678
HTS_TST_POS Test Result by Age and Sex: Positive: 25-49 Male 2017 123
HTS_TST_POS Test Result by Age and Sex: Positive: 25-49 Male 2017 468
HTS_TST_POS Test Result by Age and Sex: Positive: 50+ Female 2017 18
HTS_TST_POS Test Result by Age and Sex: Positive: 50+ Female 2017 53
HTS_TST_POS Test Result by Age and Sex: Positive: 50+ Male 2017 10
HTS_TST_POS Test Result by Age and Sex: Positive: 50+ Male 2017 39
HTS_TST_POS Test Result by Age: Positive: <1 2017 21
HTS_TST_POS Test Result by Age: Positive: 1-9 2017 15
HTS_TST_POS Test Result by Age: Positive: 1-9 2017 91
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive <15 Female 2017 32
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive <15 Female 2017 152
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive <15 Male 2017 28
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive <15 Male 2017 158
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive 15+ Female 2017 438
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive 15+ Female 2017 1,471
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive 15+ Male 2017 269
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive 15+ Male 2017 1,018
KP_PREV By key population type: Men who have sex with men who are sex workers (Numerator: Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required) 2017 97
KP_PREV Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required 2017 97
KP_PREV Total estimated number of key population in the catchment area 2017 199
KP_PREV_den By key population type: Female sex workers (FSW) (Denominator: Total estimated number of key population in the catchment area) 2017 199
OVC_SERV Age/Sex: 18+ Female 2017 476
OVC_SERV Age/Sex: 18+ Male 2017 390
OVC_SERV By Aggregated Age/Sex: <18 Female 2017 1,349
OVC_SERV By Aggregated Age/Sex: <18 Male 2017 1,263
OVC_SERV Number of active beneficiaries served by PEPFAR OVC programs for children and families affected by HIV/AIDS 2017 3,478
OVC_SERV Sum of Age/Sex disaggregates 2017 866
PMTCT_ART Already on ART at beginning of current pregnancy 2017 212
PMTCT_ART Already on ART at beginning of current pregnancy 2017 577
PMTCT_ART New on ART 2017 149
PMTCT_ART New on ART 2017 412
PMTCT_ART Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2017 12,176
PMTCT_ART Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2017 34,808
PMTCT_EID By infants who received a virologic test within 2 months of birth 2017 240
PMTCT_EID By infants who received a virologic test within 2 months of birth 2017 649
PMTCT_EID By infants who received their first virologic HIV test between 2 and 12 months of age 2017 55
PMTCT_EID By infants who received their first virologic HIV test between 2 and 12 months of age 2017 185
PMTCT_EID Number of infants with a positive virological test result within 2 months of birth 2017 10
PMTCT_EID Number of infants with a positive virological test result within 2 months of birth 2017 34
PMTCT_EID Sum of Infant Age disaggregates 2017 295
PMTCT_EID Sum of Infant Age disaggregates 2017 834
PMTCT_STAT By: Known positives at entry 2017 267
PMTCT_STAT By: Known positives at entry 2017 750
PMTCT_STAT By: Number of new positives identified 2017 109
PMTCT_STAT By: Number of new positives identified 2017 296
PMTCT_STAT Number of new ANC and L&D clients 2017 12,486
PMTCT_STAT Number of new ANC and L&D clients 2017 35,702
PMTCT_STAT Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2017 12,176
PMTCT_STAT Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2017 34,808
PMTCT_STAT Sum of Positives Status disaggregates 2017 376
PMTCT_STAT Sum of Positives Status disaggregates 2017 1,046
PP_PREV Aggregated Age/sex: <15 Female 2017 207
PP_PREV Aggregated Age/sex: <15 Male 2017 190
PP_PREV Aggregated Age/sex: 15+ Female 2017 242
PP_PREV Aggregated Age/sex: 15+ Male 2017 245
PP_PREV Number of the target population who completed a standardized HIV prevention intervention including the minimum components during the reporting period 2017 849
PP_PREV Total number of people in the target population 2017 2,437
PrEP_NEW Female 15-19 2017 101
PrEP_NEW Female 20-24 2017 46
PrEP_NEW Female 25-49 2017 27
PrEP_NEW Female 50+ 2017 3
PrEP_NEW Male 15-19 2017 74
PrEP_NEW Male 20-24 2017 20
PrEP_NEW Male 25-49 2017 27
PrEP_NEW Male 50+ 2017 2
PrEP_NEW Number of individuals who have received antiretroviral preexposure 2017 300
TB_ART Aggregated Age/Sex: Female 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 4
TB_ART Aggregated Age/Sex: Female 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 42
TB_ART Aggregated Age/Sex: Male 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 20
TB_ART Aggregated Age/Sex: Male 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 131
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period 2017 24
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period 2017 173
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period 2017 24
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period 2017 173
TB_SCREENDX [Sub-Disagg of Screen Result] Specimen Sent: Specimen sent for bacteriologic diagnosis of active TB 2017 2,016
TB_SCREENDX [Sub-Disagg of Screen Results] Specimen Sent: Specimen sent for bacteriologic diagnosis of active TB 2017 272
TB_SCREENDX [Sub-disagg of Specimen Sent] Diagnostic Test: Other (Not Xpert) 2017 29
TB_SCREENDX [Sub-Disagg of Specimen Sent] Diagnostic Test: other (not Xpert) 2017 195
TB_SCREENDX [Sub-disagg of Specimen Sent] Diagnostic Test: Smear Only 2017 80
TB_SCREENDX [Sub-Disagg of Specimen Sent] Diagnostic Test: Smear only 2017 609
TB_SCREENDX [Sub-disagg of Specimen Sent] Diagnostic Test: Xpert MTB/RIF assay 2017 163
TB_SCREENDX [Sub-Disagg of Specimen Sent] Diagnostic Test: Xpert MTB/RIF assay 2017 1,212
TB_SCREENDX Screen Result: Screened Positive for TB 2017 503
TB_SCREENDX Screen Results: Screened Positive for TB 2017 67
TB_SCREENDX Screened for TB by Age/Sex: <15 Female 2017 153
TB_SCREENDX Screened for TB by Age/Sex: <15 Male 2017 136
TB_SCREENDX Screened for TB by Age/Sex: 15+ Female 2017 2,050
TB_SCREENDX Screened for TB by Age/Sex: 15+ Female 2017 15,424
TB_SCREENDX Screened for TB by Age/Sex: 15+ Male 2017 1,056
TB_SCREENDX Screened for TB by Age/Sex: 15+ Male 2017 7,937
TB_SCREENDX Screened for TB by Age/Sex:<15 Female 2017 962
TB_SCREENDX Screened for TB by Age/Sex:<15 Male 2017 854
TB_SCREENDX The number of PLHIV who were screened for TB symptoms at the last clinical visit at a HIV facility during the reporting period 2017 25,177
TB_SCREENDX The number of PLHIV who were screened for TB symptoms at the last clinical visit at a HIV facility during the reporting period 2017 3,395
TB_STAT Aggregated Age/Sex: Female <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 12
TB_STAT Aggregated Age/Sex: Female 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 25
TB_STAT Aggregated Age/Sex: Female 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 246
TB_STAT Aggregated Age/Sex: Male <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 16
TB_STAT Aggregated Age/Sex: Male 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 48
TB_STAT Aggregated Age/Sex: Male 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 448
TB_STAT Number of registered new and relapsed TB cases with documented HIV status, during the reporting period 2017 73
TB_STAT Number of registered new and relapsed TB cases with documented HIV status, during the reporting period 2017 722
TB_STAT Total number of registered new and relapsed TB cases, during the reporting period 2017 73
TB_STAT Total number of registered new and relapsed TB cases, during the reporting period 2017 722
TX_CURR Age/Sex: <1 2017 4
TX_CURR Age/Sex: <1 2017 63
TX_CURR Age/Sex: <1-9 2017 443
TX_CURR Age/Sex: 1-9 2017 76
TX_CURR Age/Sex: 10-14 Female 2017 112
TX_CURR Age/Sex: 10-14 Female 2017 701
TX_CURR Age/Sex: 10-14 Male 2017 97
TX_CURR Age/Sex: 10-14 Male 2017 609
TX_CURR Age/Sex: 15-19 Female 2017 104
TX_CURR Age/Sex: 15-19 Female 2017 776
TX_CURR Age/Sex: 15-19 Male 2017 30
TX_CURR Age/Sex: 15-19 Male 2017 240
TX_CURR Age/Sex: 20-24 Female 2017 473
TX_CURR Age/Sex: 20-24 Female 2017 3,550
TX_CURR Age/Sex: 20-24 Male 2017 210
TX_CURR Age/Sex: 20-24 Male 2017 1,591
TX_CURR Age/Sex: 25-49 Female 2017 1,369
TX_CURR Age/Sex: 25-49 Female 2017 10,322
TX_CURR Age/Sex: 25-49 Male 2017 761
TX_CURR Age/Sex: 25-49 Male 2017 5,708
TX_CURR Age/Sex: 50+ Female 2017 104
TX_CURR Age/Sex: 50+ Female 2017 776
TX_CURR Age/Sex: 50+ Male 2017 55
TX_CURR Age/Sex: 50+ Male 2017 398
TX_CURR Aggregated Age/Sex: <15 Female 2017 153
TX_CURR Aggregated Age/Sex: <15 Female 2017 962
TX_CURR Aggregated Age/Sex: <15 Male 2017 136
TX_CURR Aggregated Age/Sex: <15 Male 2017 854
TX_CURR Aggregated Age/Sex: 15+ Female 2017 2,050
TX_CURR Aggregated Age/Sex: 15+ Female 2017 15,424
TX_CURR Aggregated Age/Sex: 15+ Male 2017 1,056
TX_CURR Aggregated Age/Sex: 15+ Male 2017 7,937
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2017 3,395
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2017 25,177
TX_CURR Sum of age/sex disaggregates 2017 1,016
TX_CURR Sum of Age/Sex disaggregations 2017 134
TX_CURR Sum of Aggregated Age/Sex <15 2017 289
TX_CURR Sum of Aggregated Age/Sex <15 2017 1,816
TX_CURR Sum of Aggregated Age/Sex 15+ 2017 3,106
TX_CURR Sum of Aggregated Age/Sex 15+ 2017 23,361
TX_CURR Sum of Aggregated Age/Sex disaggregates 2017 3,395
TX_CURR Sum of Aggregated Age/Sex disaggregates 2017 25,177
TX_NEW Aggregated Grouping by Age/Sex: <15 Female 2017 33
TX_NEW Aggregated Grouping by Age/Sex: <15 Female 2017 176
TX_NEW Aggregated Grouping by Age/Sex: <15 Male 2017 18
TX_NEW Aggregated Grouping by Age/Sex: <15 Male 2017 138
TX_NEW Aggregated Grouping by Age/Sex: 15+ Female 2017 591
TX_NEW Aggregated Grouping by Age/Sex: 15+ Female 2017 2,132
TX_NEW Aggregated Grouping by Age/Sex: 15+ Male 2017 304
TX_NEW Aggregated Grouping by Age/Sex: 15+ Male 2017 1,096
TX_NEW By Age/Sex: <1 2017 2
TX_NEW By Age/Sex: 1-9 2017 6
TX_NEW By Age/Sex: 1-9 2017 72
TX_NEW By Age/Sex: 10-14 Female 2017 31
TX_NEW By Age/Sex: 10-14 Female 2017 142
TX_NEW By Age/Sex: 10-14 Male 2017 14
TX_NEW By Age/Sex: 10-14 Male 2017 98
TX_NEW By Age/Sex: 15-19 Female 2017 31
TX_NEW By Age/Sex: 15-19 Female 2017 109
TX_NEW By Age/Sex: 15-19 Male 2017 6
TX_NEW By Age/Sex: 15-19 Male 2017 30
TX_NEW By Age/Sex: 20-24 Female 2017 137
TX_NEW By Age/Sex: 20-24 Female 2017 493
TX_NEW By Age/Sex: 20-24 Male 2017 62
TX_NEW By Age/Sex: 20-24 Male 2017 221
TX_NEW By Age/Sex: 25-49 Female 2017 395
TX_NEW By Age/Sex: 25-49 Female 2017 1,427
TX_NEW By Age/Sex: 25-49 Male 2017 219
TX_NEW By Age/Sex: 25-49 Male 2017 792
TX_NEW By Age/Sex: 50+ Female 2017 28
TX_NEW By Age/Sex: 50+ Female 2017 103
TX_NEW By Age/Sex: 50+ Male 2017 17
TX_NEW By Age/Sex: 50+ Male 2017 53
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2017 946
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2017 3,542
TX_NEW Sum of Age/Sex disaggregates 2017 940
TX_NEW Sum of Age/Sex disaggregates 2017 3,468
TX_NEW Sum of Aggregated Age/Sex disaggregates 2017 946
TX_NEW Sum of Aggregated Age/Sex disaggregates 2017 3,542
VMMC_CIRC By Age: 10-14 2017 4,709
VMMC_CIRC By Age: 15-19 2017 3,502
VMMC_CIRC By Age: 20-24 2017 1,691
VMMC_CIRC By Age: 25-29 2017 965
VMMC_CIRC By Age: 30-49 2017 965
VMMC_CIRC By Age: 50+ 2017 243
VMMC_CIRC By circumcision technique: Surgical VMMC 2017 12,075
VMMC_CIRC Number of males circumcised as part of the voluntary medical male circumcision (VMMC) for HIV prevention program within the reporting period 2017 12,075
VMMC_CIRC Sum of age disaggregates (FY15-Current) 2017 12,075
VMMC_CIRC Sum of age disaggregates (Prior to FY15) 2017 10,145
Mechanism Allocation by Budget Code for Selected Year
6.1%7.6%9.1%10.6%12.1%13.6%15.2%16.7%0-10123456789101112HBHCHKIDHVTBPDCSHLABOHSSCIRCHVCTHVOPMTCTHTXSPDTX